Predictors | All (n = 433) | Training (n = 359) | Life-threatening complications | P Value | |
---|---|---|---|---|---|
Yes (n = 77) | No (n = 282) | ||||
Age, median (IQR), years | 51.0 (38.0–61.0) | 51.0 (37.0–61.0) | 61.0 (53.0–67.5) | 46.0 (35.0–58.0) |  < .001 |
Sex, male, n (%) | 305 (70.4) | 246 (68.5) | 53 (68.8) | 193 (68.4) | .948 |
Antibiotic allergy, n (%) | 24 (5.5) | 22 (6.1) | 7 (9.1) | 15 (5.4) | .280 |
Smoking, n (%) | 108 (24.9) | 88 (24.5) | 18 (23.4) | 70 (24.8) | .794 |
Alcoholism, n (%) | 39 (9.0) | 31 (8.6) | 9 (11.7) | 22 (7.8) | .282 |
Body temperature, median (IQR), ℃ | 36.6 (36.4–36.9) | 36.6 (36.4–36.9) | 36.6 (36.5–37.0) | 36.6 (36.4–36.8) | .338 |
Heart rate, median (IQR), bpm | 87.0 (78.0–100.0) | 87.0 (78.0–99.0) | 92.0 (80.0–110.0) | 86.0 (77.8–97.3) | .002 |
Diabetes mellitus, n (%) | 113 (26.1) | 96 (26.7) | 31 (40.3) | 65 (23.0) | .002 |
Hypertension, n (%) | 65 (15.0) | 52 (14.5) | 18 (23.4) | 34 (12.1) | .012 |
Multispace involvement, n (%) | 213 (49.2) | 176 (49.0) | 69 (89.6) | 107 (37.9) |  < .001 |
Gas formation, n (%) | 127 (29.3) | 103 (28.7) | 54 (70.1) | 49 (17.4) |  < .001 |
Initial onset of symptoms and signs | Â | Â | Â | Â | Â |
 Pharyngalgia, n (%) | 293 (67.7) | 238 (66.3) | 57 (74.0) | 181 (64.2) | .105 |
 Odynophagia, n (%) | 241 (55.7) | 198 (55.2) | 51 (66.2) | 147 (52.1) | .027 |
 Neck pain, n (%) | 289 (66.7) | 231 (64.3) | 47 (61.0) | 184 (65.2) | .494 |
 Neck swelling, n (%) | 256 (59.1) | 210 (58.5) | 45 (58.4) | 165 (58.5) | .991 |
 Dysphagia, n (%) | 185 (42.7) | 151 (42.1) | 44 (57.1) | 107 (37.9) | .002 |
 Trismus, n (%) | 94 (21.7) | 74 (20.6) | 13 (16.9) | 61 (21.6) | .361 |
 Hoarseness, n (%) | 30 (6.9) | 26 (7.2) | 10 (13.0) | 16 (5.7) | .028 |
 Dyspnea, n (%) | 63 (14.5) | 50 (13.9) | 32 (41.6) | 18 (6.4) |  < .001 |
Primary regions of infection | Â | Â | Â | Â | Â |
 Suprahyoid region, n (%) | 295 (68.1) | 244 (68.0) | 56 (72.7) | 188 (66.7) | .312 |
 Infrahyoid region, n (%) | 96 (22.2) | 78 (21.7) | 4 (5.2) | 74 (26.2) |  < .001 |
 Retropharyngeal region, n (%) | 42 (9.7) | 37 (10.3) | 17 (22.1) | 20 (7.1) |  < .001 |
Laboratory test | Â | Â | Â | Â | Â |
 NEUT, median (IQR), 109/L | 10.8 (7.7–14.5) | 10.8 (7.5–14.5) | 13.4 (9.8–17.5) | 10.4 (7.2–13.9) |  < .001 |
 PLR, median (IQR) | 181.4 (132.0–258.2) | 183.3 (132.5–259.1) | 235.4 (170.8–354.4) | 173.4 (125.3–227.5) |  < .001 |
 RBC, median (IQR), 1012/L | 4.6 (4.2–5.0) | 4.6 (4.2–5.0) | 4.5 (4.0–4.9) | 4.6 (4.3–5.0) | .007 |
 Hb, median (IQR), g/L | 135.0 (123.0–147.0) | 135.0 (123.0–146.0) | 132.0 (118.0–144.5) | 136.0 (124.8–148.0) | .071 |
 Blood glucose, median (IQR), mmol/L | 6.1 (5.1–9.5) | 6.1 (5.1–9.4) | 8.4 (6.4–12.1) | 5.8 (5.0–8.1) |  < .001 |
 Albumin, median (IQR), g/L | 38.1 (33.5–42.5) | 38.2 (33.5–42.6) | 31.8 (27.0–36.0) | 39.2 (36.0–43.3) |  < .001 |